Epidemiological burden, risk factors, and recent therapeutic advances in chronic obstructive pulmonary disease
Chronic Obstructive Pulmonary Disease (COPD) is a progressive disease that is certainly preventable and treatable and is caused due to the continuous exposure to noxious substances and toxic gases and is characterized by airflow limitation and chronic inflammation in the lungs coupled with persisten...
Main Authors: | Ayilya Bakthavatchalam Loganathan, Nazeer Rasool Abdul |
---|---|
Format: | Article |
Language: | English |
Published: |
Bangladesh Society for Microbiology, Immunology, and Advanced Biotechnology
2023-04-01
|
Series: | Journal of Advanced Biotechnology and Experimental Therapeutics |
Subjects: | |
Online Access: | http://www.ejmanager.com/fulltextpdf.php?mno=103731 |
Similar Items
-
Premature Mortality Due to Chronic Obstructive Pulmonary Disease (COPD) in Poland
by: Waclaw Moryson, et al.
Published: (2021-02-01) -
Prevalence of Chronic Obstructive Pulmonary Disease in Kocaeli: An Industrialised City in Turkey
by: Zeliha Arslan, et al.
Published: (2013-12-01) -
Trends in burden of chronic obstructive pulmonary disease in Iran, 1995–2015: findings from the global burden of disease study
by: Seyed Yaser Hashemi, et al.
Published: (2020-05-01) -
The Burden Of Chronic Obstructive Pulmonary Disease (COPD) In Finland: Impact Of Disease Severity And Eosinophil Count On Healthcare Resource Utilization
by: Viinanen A, et al.
Published: (2019-10-01) -
Prevalence and influence of chronic obstructive pulmonary disease on stroke outcomes in hospitalized stroke patients
by: Alain Lekoubou, MD, et al.
Published: (2017-03-01)